HIT Consultant October 9, 2024
McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology limitations, regulatory requirements, and patient recruitment and retention. Scientific innovation and clinical trials are increasingly complex, generating more data than ever. Researchers are facing difficulties managing the volume and variety of data, turning to artificial intelligence, machine learning and advanced data architecture to improve data processing, user experiences, and outcomes.
However, one less discussed challenge within the drug discovery and development lifecycle is the ability of compute power to not only advance the data infrastructure needed but to also meet the increasing data demands of new and complex clinical trials. Building on...